Andere Kunden interessierten sich auch für
![Infectious Diseases in Critical Care]( "Infectious Diseases in Critical Care")
Infectious Diseases in Critical Care147,99 €![Infectious Complications of Cancer]( "Infectious Complications of Cancer")
Infectious Complications of Cancer249,99 €![Common Infections]( "Common Infections")
Common Infections166,99 €![Tuberculosis]( "Tuberculosis")
Tuberculosis111,99 €![Opportunistic Intracellular Bacteria and Immunity]( "Opportunistic Intracellular Bacteria and Immunity")
Opportunistic Intracellular Bacteria and Immunity37,99 €![Macrolide Antibiotics]( "Macrolide Antibiotics")
Macrolide Antibiotics125,99 €![The Complement System]( "The Complement System")
The Complement System147,99 €
Discover new, effective strategies to prevent and treat sepsis. In this book, leading medical experts consider how the pathways implicated in early and late sepsis interact. Next, the book describes numerous pharmacological approaches that enable you to provide state-of-the-technology care for patients in both early and late sepsis. You'll also get detailed discussions of how the various physiological systems function under sepsis.
Sepsis is a serious medical condition, resulting from the immune response to a severe infection. Septicaemia is sepsis of the bloodstream caused by bactemeria, which is the presence of bacteria in the bloodstream. The term septecaemia is also used to refer to sepsis in general. In the US, sepsis is the leading cause of death in non-coronary ICU patients, and the tenth most common form of death overall. Sepsis is common and also more dangerous in the elderly, immunocompromised, and critically ill patients. It occurs in 1-2% of all hospitilizations and accounts for as much as 25% of all ICU bed utilization. It is a major cause of death in intensive care units worldwide, with mortality rates that range from 20% for sepsis to 40% for severe sepsis to more than 60% for septic shock. The book brings together a group of experts to consider how the various pathways implicated in early and late sepsis interact. It addresses the frequent, but under-recognised condition of sepsis and discusses new ways to prevent and treat it. It describes numerous pharmocological approaches to therapy for early and late sepsis. It includes detailed discussion of the various physiological systems implicated in sepsis. This is an invaluable resource for all critical care physicians and researchers. It is also informative reading for immunologists, endocrinologists, neuroendocrinologists, phsysiologists and pharmacologists
Drawing on multi-professional editors and authors brings in the variety of perspectives and knowledge seen within the critical care team to produce a text that is both inclusive of and targeted to the individual needs of its intended audience. The nature of the material, written and edited by experienced practitioners in the field will provide an invaluable source of reference and training material for specialists and those already trained in their field.
Sepsis is a serious medical condition, resulting from the immune response to a severe infection. Septicaemia is sepsis of the bloodstream caused by bactemeria, which is the presence of bacteria in the bloodstream. The term septecaemia is also used to refer to sepsis in general. In the US, sepsis is the leading cause of death in non-coronary ICU patients, and the tenth most common form of death overall. Sepsis is common and also more dangerous in the elderly, immunocompromised, and critically ill patients. It occurs in 1-2% of all hospitilizations and accounts for as much as 25% of all ICU bed utilization. It is a major cause of death in intensive care units worldwide, with mortality rates that range from 20% for sepsis to 40% for severe sepsis to more than 60% for septic shock. The book brings together a group of experts to consider how the various pathways implicated in early and late sepsis interact. It addresses the frequent, but under-recognised condition of sepsis and discusses new ways to prevent and treat it. It describes numerous pharmocological approaches to therapy for early and late sepsis. It includes detailed discussion of the various physiological systems implicated in sepsis. This is an invaluable resource for all critical care physicians and researchers. It is also informative reading for immunologists, endocrinologists, neuroendocrinologists, phsysiologists and pharmacologists
Drawing on multi-professional editors and authors brings in the variety of perspectives and knowledge seen within the critical care team to produce a text that is both inclusive of and targeted to the individual needs of its intended audience. The nature of the material, written and edited by experienced practitioners in the field will provide an invaluable source of reference and training material for specialists and those already trained in their field.
From the reviews:
"This brief, multiauthored monograph reviews the recent thinking on a variety of infectious disease issues. ... Practitioners seeking an update on infectious diseases as related to critical illness are an appropriate audience for this work which comes from a variety of contributors in the United Kingdom. ... Tables and multicolored type allow ready identification of key content. Photographs are used occasionally and reproduce well. Line drawings are used effectively. ... The book covers a wide ranging set of topics." (David J. Dries, Doody's Review Service, March, 2008)
"This brief, multiauthored monograph reviews the recent thinking on a variety of infectious disease issues. ... Practitioners seeking an update on infectious diseases as related to critical illness are an appropriate audience for this work which comes from a variety of contributors in the United Kingdom. ... Tables and multicolored type allow ready identification of key content. Photographs are used occasionally and reproduce well. Line drawings are used effectively. ... The book covers a wide ranging set of topics." (David J. Dries, Doody's Review Service, March, 2008)